Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
A diet deficient in calcium was considered the highest risk factor, linked to approximately one in five deaths from colon ...
Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer ...
Artemisia herba-alba shows promise in combating colorectal cancer, offering new hope through its powerful medicinal ...
About 150,000 Americans are diagnosed annually with colorectal cancer, which occurs when cells in the colon or rectum grow ...
People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutation in their PI3K genes, researchers reported at the 2025 American Society of ...
Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...